PRESS RELEASE published on 01/19/2026 at 07:30, 5 months 19 days ago Inside Information / Other news releases FDA accepts Advicenne's Marketing Authorization Application for Sibnayal® for dRTA treatment in the US, with a PDUFA decision target date of September 3rd, 2026 FDA Advicenne Sibnayal DRTA PDUFA
PRESS RELEASE published on 01/19/2026 at 07:30, 5 months 19 days ago Informations privilégiées / Autres communiqués Advicenne annonce l'acceptation de Sibnayal pour examen par la FDA aux Etats-Unis pour le traitement de l’ATRd. Date PDUFA fixée au 3 septembre 2026 FDA Advicenne ATRd Sibnayal PDUFA
BRIEF published on 01/12/2026 at 07:35, 5 months 26 days ago Renewal of the marketing authorization for Sibnayal® in the European Union Kidney Disease EMA Advicenna AMM Sibnayal®
BRIEF published on 01/12/2026 at 07:35, 5 months 26 days ago Renouvellement de l'AMM de Sibnayal® dans l'Union Européenne Advicenne Maladies Rénales EMA AMM Sibnayal®
PRESS RELEASE published on 01/12/2026 at 07:30, 5 months 26 days ago Informations privilégiées / Autres communiqués Advicenne annonce le succès du renouvellement de l’AMM de Sibnayal® dans l’Union Européenne. L'EMA a validé l'autorisation de mise sur le marché, renforçant le développement commercial de Sibnayal® Renouvellement Union Européenne Advicenne AMM Sibnayal
BRIEF published on 11/04/2025 at 11:35, 8 months 2 days ago Advicenne submits Sibnayal® to the US FDA FDA Advicenna Sibnayal® Renal Tubular Acidosis Registration Filing
BRIEF published on 11/04/2025 at 11:35, 8 months 2 days ago Advicenne soumet Sibnayal® à la FDA américaine FDA Advicenne Sibnayal® Acidose Tubulaire Rénale Dépôt D'enregistrement
PRESS RELEASE published on 11/04/2025 at 11:30, 8 months 2 days ago Inside Information / Other news releases Advicenne submits registration application for Sibnayal® in dRTA treatment to US FDA, designated orphan drug. Evaluation process expected to take 12 months Advicenne Sibnayal® US FDA DRTA Treatment Registration Application
PRESS RELEASE published on 11/04/2025 at 11:30, 8 months 2 days ago Informations privilégiées / Autres communiqués Advicenne dépose le dossier d'enregistrement de Sibnayal® auprès de la FDA américaine pour le traitement de l'ATRd. Webconférence le 5 novembre 2025. Informations sur ADV7103 et le développement clinique FDA Advicenne Webconférence ATRd Sibnayal
BRIEF published on 09/19/2025 at 18:05, 9 months 17 days ago Advicenne: Half-year results in 2025 and outlook Financial Results Outlook Turnover United States Sibnayal®
Published on 07/07/2026 at 09:05, 55 minutes ago HM Exploration Expands Newly Discovered Blind Massive Sulphide Lens at Lewis Pilley's Project
Published on 07/07/2026 at 09:01, 59 minutes ago Star Copper Begins Step-Out Drilling at Star Main Location to Test Northeast Extension of Hypogene System
Published on 07/06/2026 at 23:32, 10 hours 28 minutes ago Marrelli Capital Limited - Early Warning Regarding Acquisition of Common Shares of BE Resources Inc.
Published on 07/06/2026 at 23:30, 10 hours 30 minutes ago 1742096 Ontario Ltd. - Early Warning Regarding Acquisition of Common Shares of BE Resources Inc.
Published on 07/06/2026 at 19:25, 14 hours 35 minutes ago Critical Elements Provides an Update on Its 10,000-Meter Summer Drill Program at Rose West
Published on 07/07/2026 at 09:05, 54 minutes ago RBC appoints Sian Hurrell and Robin Beer as Co-CEOs to accelerate European growth
Published on 07/07/2026 at 09:00, 1 hour ago ENOGIA: Bilan semestriel du contrat de liquidité d’ENOGIA au 30 juin 2026
Published on 07/07/2026 at 08:30, 1 hour 30 minutes ago RBI on the interim status of acceptances of the voluntary public tender offer for all Addiko shares as of 6 July 2026
Published on 07/06/2026 at 18:00, 16 hours ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 26 juin 2026
Published on 07/06/2026 at 18:00, 16 hours ago Information concerning the total number of voting rights and shares in the share capital as of June 26, 2026
Published on 07/06/2026 at 18:00, 16 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 juin 2026
Published on 07/06/2026 at 17:59, 16 hours ago Acquisition of Xypex in construction chemicals, a leader in high value-added waterproofing solutions
